Portrait Oliver Distler

Oliver Distler
Prof. Dr. med.

Director of Department, Department of Rheumatology

Other functions at USZ

  • Center Manager Spine Center

Specialties

  • Systemic sclerosis
  • Connective tissue disease
  • Systemic diseases

Contact

Tel. +41 44 255 29 70
VCard

Research area

Systemic sclerosis, fibrosis, interstitial lung disease in collagenoses.

Expertise: clinical trials, drug development strategies, biomarkers, RNA-omics, animal models, registry analysis, in vitro functional testing for fibrosis.

Career

2016 Director of the Department of Rheumatology, University Hospital Zurich
2015-2017 Visiting Professor University of Florence, Italy
2015 Visiting Professor Stanford University, USA
2013 Professor ad personam, University of Zurich
2012 Certificate of Advanced Studies in Healthcare Management, University of St. Gallen
2012 Visiting Professor University of Gothenburg, Sweden
2009-2016 Senior Attending Physician and Director Scleroderma Program, Department of Rheumatology, University Hospital
2006-2009 Attending Physician, Department of Rheumatology, University Hospital Zurich
2006 Specialist FMH for Rheumatology
2004/2005 Specialist FMH for Internal Medicine
2005 Habilitation as Privatdozent for Rheumatology, University of Zurich
2004-2006 Resident, Department of Immunology and Rheumatology, University Hospital Zurich
1998-2004 Postdoctoral Researcher Center for Experimental Rheumatology, University Hospital Zurich
1997 Doctoral thesis at the University of Erlangen
1989-1996 Medical studies, University of Erlangen, Germany

Most important memberships

  • Chair Executive Committee of the FOREUM Foundation (Foundation for Research in Rheumatology)
  • Co-Chair of ERS/EULAR Guidelines (European Respiratory Society)
  • Member scientific evaluation board, Pfizer Research Foundation
  • Member Foundation Board, SCQM (Swiss Clinical Quality Management in Rheumatic Diseases)
  • Member Walter-Siegenthaler-Gesellschaft für Fortschritte in der Inneren Medizin
  • Scientific advisory board of the AbbVie Rheumatology Grant
  • Scientific advisory board GILS (Gruppo Italiano per la Lotta alla Sclerodermia) Foundation
  • Member scientific committee Swiss Society of Rheumatology (SGR)

Research focus

  • Systemic sclerosis

Publications

Publication list

Further

  • Head of the Center for Experimental Rheumatology at the University Hospital Zurich

Vested interests

Since Assignment Client City
05.05.2026 Instructor mRSS Boehringer Ingelheim International GmbH Ingelheim am Rhein, DE
10.04.2026 Berater Klinisches Studienprotokoll Oxion Biologics AB Stockholm, SE
01.04.2026 Mitglied Advisory Board Phase 3b Studie Boehringer Ingelheim International GmbH Ingelheim am Rhein, DE
10.02.2026 Chair Data Safety and Monitoring Board Quell Therapeutics London, GB
09.01.2026 Berater Amgen Inc. California, US
01.01.2026 Mitglied Advisory Board Phase 3 Studie Boehringer Ingelheim International GmbH Ingelheim am Rhein, DE
01.11.2025 Mitglied Advisory Board Phase 2 Studie Bristol-Myers Squibb Company Lawrenceville, NJ, US
01.09.2025 Berater Tandem Therapeutics AG (start up) Schlieren
06.08.2025 Jury Pfizer Forschungspreis Stiftung Pfizer c/o Pfizer AG Zürich
01.05.2025 Berater Hemetron AG (Start up) Thalwil
01.02.2025 Gründer Association for Lung in Rheumatic Diseases Basel
16.01.2025 Global Coordinating Investigator, Phase 2 Studie Galderma Research & Development LLC. Dallas, Texas, US
10.12.2024 Berater Galderma Research & Development, LLC. Dallas, Texas, US
25.04.2024 Berater Orion Biotechnoloyg Zug
01.02.2024 Berater, Mitglied Advisory Board, Phase 2 Studie MSD Merck Sharp & Dohme AG Luzern
01.03.2023 Mitgründer Citus AG (Start up) Dübendorf
23.03.2021 Chair Executive Committee FOREUM Foundation for Research in Rheumatology Kilchberg
20.06.2016 Jury Rheumatology Fellowship Programm AbbVie AG Cham